SC
CRL icon

Sculptor Capital’s Charles River Laboratories CRL Stock Holding History

Sculptor Capital’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-18,582
Closed -$7M – 1241
2021
Q4 		$7M Sell
18,582
-21,688
-54% -$8.43M 0.06% 283
2021
Q3 		$16.6M Sell
40,270
-23,474
-37% -$9.75M 0.14% 104
2021
Q2 		$23.6M Sell
63,744
-15,914
-20% -$5.31M 0.17% 89
2021
Q1 		$23.1M Sell
79,658
-99,496
-56% -$27.7M 0.19% 82
2020
Q4 		$44.8M Sell
179,154
-168,949
-49% -$40.2M 0.19% 60
2020
Q3 		$78.8M Sell
348,103
-64,823
-16% -$13.5M 0.5% 33
2020
Q2 		$72M Sell
412,926
-47,542
-10% -$7.59M 0.61% 34
2020
Q1 		$58.1M Buy
460,468
+882
+0.2% +$132K 0.82% 25
2019
Q4 		$70.2M Buy
459,586
+22,500
+5% +$3.12M 0.74% 30
2019
Q3 		$57.9M Buy
437,086
+54,340
+14% +$7.29M 0.62% 38
2019
Q2 		$54.3M Buy
382,746
+77,700
+25% +$10.5M 0.29% 51
2019
Q1 		$44.3M Buy
+305,046
New +$40.1M 0.26% 48

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Sculptor Capital's CRL Position: Q1 2022 in Review

Sculptor Capital sold out of Charles River Laboratories (CRL) in Q1 2022, closing a stake of 18,582 shares — an estimated $7M sold.

Sculptor Capital first reported a position in CRL in Q1 2019 and held it in 12 quarters. The position peaked at $78.8M in Q3 2020. 644 funds tracked by Wall St. Rank hold CRL as of Q1 2022.

  • Sculptor Capital reported no remaining Charles River Laboratories position as of Q1 2022 after selling out during the quarter.
  • Sculptor Capital sold 18,582 Charles River Laboratories shares in Q1 2022, an estimated $7M.
  • Sculptor Capital first reported a position in Charles River Laboratories in Q1 2019 and held it in 12 quarters.
  • Sculptor Capital's Charles River Laboratories position peaked at $78.8M in Q3 2020.
  • 644 funds tracked by Wall St. Rank held Charles River Laboratories as of Q1 2022.

Based on Sculptor Capital's 13F filing for Q1 2022, filed 13 May 2022.